The latest updates from your pharmaceutical service provider

The pharmaceutical industry is developing rapidly, and so is our company. In our news area, we keep you up to date on current developments and news relating to our business. Voigt Industrie Service AG is changing with the times – find out more and benefit from our innovations.

avosano moves into the future

22.09.2023

PHOENIX Pharma Switzerland AG and family firm Voigt Holding AG founded a 50/50 joint venture in the form of avosano AG at the end of April 2023, combining pharma wholesale (Amedis-UE AG and Voigt AG Pharma Grosshandel) and pre-wholesale (Voigt Industrie Service AG) activities under one roof.

Read More
avosano AG: Deal closed

02.05.2023

On 28 April 2023, the Voigt Group and PHOENIX Pharma Switzerland completed the transaction for the 50/50 joint venture avosano with the closing. Under the umbrella of avosano the two companies are combining their pharmaceutical wholesale and prewholesale activities.

Read More
Joint venture planned

18.10.2022

The Voigt Group and PHOENIX Pharma Switzerland intend to bring their subsidiaries Voigt AG and Voigt Industrie Service AG, respectively Amedis-UE AG, into a 50/50 joint venture.

Read More
Donation campaign Ukraine

17.03.2022

Together with our employees we started a donation campaign last week. The total amount was donated to Swiss Solidarity today.

Read More
Cooperation with Lamprecht Pharma Logistics AG

04.03.2021

Voigt Industrie Service (VIS) and Lamprecht Pharma Logistics (LPL) have worked out a concept of cooperation with the aim to combine both core competences.

Read More
Pharma Campus in Niederbipp

03.04.2020

The Pharma Campus is being developed at the Niederbipp site, which will become a new skill and service centre for the healthcare business.

Read More
Pharma Campus in Niederbipp

04.09.2019

The Pharma Campus is being developed at the Niederbipp site, which will become a new skill and service centre for the healthcare business.

Read More
Serialisation

04.09.2019

We’re ready for the future. By investing in a Hicof machine, along with the necessary software, we’re ready to begin with the serialisation of pharmaceuticals in compliance with EU Falsified Medicine Directive

Read More